世界の3D細胞培養市場：製品別（ハイドロゲル、ハンギングドロップ、バイオリアクター、マイクロフルイディクス、磁気浮上）、用途別（がん、幹細胞、毒性学、組織工学）、エンドユーザー別（医薬品、バイオテクノロジー、化粧品）、地域別...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.2 Research Methodology Steps
2.2.1 Secondary Data
2.2.1.1 Secondary Sources
2.2.2 Primary Data
2.2.3 Primary Sources
2.2.4 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.3.1 Revenue Mapping-Based Market Estimation
2.4 Market Data Estimation and Triangulation
2.5 Assumptions of the Study
3 Executive Summary (Page No. – 30)
4 Premium Insights (Page No. – 33)
4.1 3D Cell Culture: Market Overview
4.2 Scaffold-Based 3D Cell Cultures Market, By Type, 2019–2024 (USD Million)
4.3 Market Share, By End User & Region, 2018
4.4 Market: Geographic Growth Opportunities
5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Focus on Developing Alternatives to Animal Testing
5.2.1.2 Growing Focus on Personalized Medicine
5.2.1.3 Increasing Incidence of Chronic Diseases
5.2.1.4 Availability of Funding for Research
5.2.2 Restraints
5.2.2.1 Lack of Infrastructure for 3D Cell-Based Research
5.2.2.2 High Cost of Cell Biology Research
5.2.3 Opportunities
5.2.3.1 Emergence of Microfluidics-Based 3D Cell Culture
5.2.3.2 Emerging Economies
5.2.3.3 Regenerative Medicine—An Alternative to Organ Transplantation
5.2.4 Challenges
5.2.4.1 Lack of Consistency in 3D Cell Culture Products
6 3D Cell Culture Market, By Product (Page No. – 43)
6.1 Introduction
6.2 Scaffold-Based 3D Cell Cultures
6.2.1 Hydrogels/ECM Analogs
6.2.1.1 Hydrogels/ECM Analogs Dominate the Scaffold-Based 3D Cell Cultures Market
6.2.2 Solid Scaffolds
6.2.2.1 Solid Scaffolds are Widely Adopted in Regenerative Medicine and Preclinical in Vitro Testing
6.2.3 Micropatterned Surfaces
6.2.3.1 Micropatterned Surfaces Enhance the Expression of Enzymes Levels and Drug Reactivity
6.3 Scaffold-Free 3D Cell Cultures
6.3.1 Low Attachment Plates
6.3.1.1 Low Attachment Plates are Expected to Grow at the Highest Rate in the Scaffold-Free 3D Cell Cultures Market
6.3.2 Hanging Drop Plates
6.3.2.1 Hanging Drop Plates are Widely Used in Stem Cell Differentiation and Cytotoxicity Research
6.3.3 3D Bioreactors
6.3.3.1 3D Bioreactors are Commonly Used for the Mass Production of Cells and Tissue Engineering Application
6.3.4 3D Petri Dishes
6.3.4.1 Europe Will Show the Highest Growth in the 3D Petri Dishes Market
6.4 Microfluidics-Based 3D Cell Cultures
6.4.1 Microfluidics-Based 3D Cell Cultures Will Grow at the Highest Rate in the Market
6.5 Magnetic & Bioprinted 3D Cell Cultures
6.5.1 3D Cell Culture Can Be Formed Without Media in Magnetic Levitation
7 3D Cell Culture Market, By Application (Page No. – 64)
7.1 Introduction
7.2 Cancer & Stem Cell Research
7.2.1 Rising Prevalence of Cancer is Supporting the Growth of This Application Segment
7.3 Drug Discovery & Toxicology Testing
7.3.1 Increasing Adoption of Personalized Medicines to Drive the Growth of This Market
7.4 Tissue Engineering & Regenerative Medicine
7.4.1 Europe is Expected to Register the Highest Growth in the Tissue Engineering & Regenerative Medicine Market
8 3D Cell Culture Market, By End User (Page No. – 71)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Stability and Long Lifespans of 3D Cell Culture Models have Driven Market Growth
8.3 Research Institutes
8.3.1 Increasing Government Funding for Research and High Prevalence of Cancer are Driving Market Growth
8.4 Cosmetics Industry
8.4.1 Focus on Developing Alternatives to Animal Testing is A Key Factor Driving Market Growth
8.5 Other End Users
9 3D Cell Culture Market, By Region (Page No. – 80)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US to Dominate the North American Market
9.2.2 Canada
9.2.2.1 Advancements in the Field of Regenerative Medicine to Drive Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Investment By Various Key Players and Growing Funding From Government Organizations to Drive the Market
9.3.2 UK
9.3.2.1 Growth in the Life Science Industry to Drive Market Growth in the UK
9.3.3 France
9.3.3.1 Growth in the Biotechnology Industry to Drive Market Growth in France
9.3.4 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Japan to Dominate the Asia Pacific Market
9.4.2 China
9.4.2.1 Government Support and Strategic Initiatives By Key Players to Strengthen the Biotechnology Sector in China
9.4.3 India
9.4.3.1 Growth in the Life Science Industry to Support Market Growth in India
9.4.4 RoAPAC
9.5 Rest of the World
10 Competitive Landscape (Page No. – 115)
10.1 Overview
10.2 Market Shares Analysis, 2018
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Dynamic Differentiators
10.3.3 Innovators
10.3.4 Emerging Companies
10.4 Competitive Situation and Trends
10.4.1 Product Launches and Upgrades
10.4.2 Expansions
10.4.3 Acquisitions
10.4.4 Partnerships, Agreements, Alliances, and Collaborations
10.4.5 Other Strategies
11 Company Profiles (Page No. – 121)
(Business Overview, Products Offered, Recent Developments & MnM View)*
11.1 Thermo Fisher Scientific
11.2 Corning Incorporated
11.3 Merck KGaA
11.4 Lonza Group
11.5 REPROCELL
11.6 3D Biotek LLC
11.7 Emulate, Inc.
11.8 CN Bio Innovations Limited
11.9 Hamilton Company
11.1 Insphero AG
11.11 Kirkstall, Ltd.
11.12 MIMETAS BV
11.13 TissUse GmbH
11.14 Synthecon Incorporated
11.15 QGel SA
11.16 Other Key Players
11.16.1 Greiner Bio-One International GmbH
11.16.2 Promocell GmbH
11.16.3 Advanced Biomatrix, Inc.
11.16.4 Hµrel Corporation
11.16.5 Synvivo, Inc.
*Details on Business Overview, Products Offered, Recent Developments & MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 150)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details